| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |